Blood solids

Blood solids is a collective physiological term that encompasses the non-liquid constituents of whole blood, primarily consisting of formed elements such as red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes), alongside essential plasma proteins like albumin and fibrinogen [1][2][4]. These components are responsible for critical systemic functions, including oxygen delivery via hemoglobin, immune surveillance, and the initiation of the coagulation cascade to prevent hemorrhage [1][3]. While blood solids do not represent a single molecular target, they are the physiological focus of various medical interventions; for instance, topical hemostatic agents like microporous polysaccharide hemospheres function by rapidly dehydrating blood to concentrate these solids into a gelled matrix that accelerates clot formation [5][9]. Monitoring the concentration of blood solids through parameters such as hematocrit is vital for diagnosing and managing conditions like anemia, leukemia, and fluid volume overload in heart failure [4][6]. Because the term refers to a heterogeneous mixture of cells and molecules rather than a specific protein or receptor, it is classified as a physiological aggregate in clinical and pharmacological contexts.

Other names

Formed elements of bloodCellular components of bloodBlood cells and proteinsSolid components of blood

Drugs and devices interacting with blood solids typically work by modulating their production in the bone marrow (e.g., erythropoietin), inhibiting their aggregation (e.g., anticoagulants), or physically concentrating them to promote rapid hemostasis through dehydration and gelation (e.g., topical hemostatic particles) [5][9][11].